Ventrinova
VentriNova is revolutionizing cardiac regenerative medicine by reversing cardiac damage pharmacologically.
Operating in clinical trials, genetics, therapeutics based in Greater New York Area, East Coast, Northeastern US, Ventrinova was founded in 2006.
Within the clinical trials, genetics, therapeutics space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in Greater New York Area, East Coast, Northeastern US.
Its current recorded stage is Seed.
Its team size is recorded as c_00001_00010 employees.
Total disclosed funding stands at about $1M.
| Sector | Clinical Trials, Genetics, Therapeutics |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2006 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $1,000,000 |
Website: www.ventrinovainc.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account